The role of receptor for advanced glycation endproducts (RAGE) in infection

[1]  D. Frommhold,et al.  RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. , 2010, Blood.

[2]  S. Akira,et al.  A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release , 2010, Proceedings of the National Academy of Sciences.

[3]  T. van der Poll,et al.  Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis* , 2010, Critical care medicine.

[4]  P. Reynolds,et al.  Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice. , 2010, American journal of respiratory cell and molecular biology.

[5]  Carsten Ehrhardt,et al.  The Receptor for Advanced Glycation End Products (RAGE) and the Lung , 2010, Journal of biomedicine & biotechnology.

[6]  Yang Liu,et al.  CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns. , 2009, Trends in immunology.

[7]  T. van der Poll,et al.  Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. , 2009, The Journal of infectious diseases.

[8]  T. van der Poll,et al.  Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia. , 2009, Virology.

[9]  M. Nishibori,et al.  Establishment of in vitro binding assay of high mobility group box-1 and S100A12 to receptor for advanced glycation endproducts: heparin's effect on binding. , 2009, Acta medica Okayama.

[10]  T. van der Poll,et al.  The Receptor for Advanced Glycation End Products Impairs Host Defense in Pneumococcal Pneumonia1 , 2009, The Journal of Immunology.

[11]  S. Akira,et al.  ROLE OF TOLL-LIKE RECEPTORS 2 AND 4, AND THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS IN HIGH-MOBILITY GROUP BOX 1-INDUCED INFLAMMATION IN VIVO , 2009, Shock.

[12]  K. Preissner,et al.  Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. , 2008, American journal of respiratory cell and molecular biology.

[13]  M. Büchler,et al.  sRAGE is elevated in septic patients and associated with patients outcome. , 2008, The Journal of surgical research.

[14]  N. Sevenet,et al.  Gene profiling in human blood leucocytes during recovery from septic shock , 2008, Intensive Care Medicine.

[15]  N. Kaminski,et al.  A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. , 2008, The American journal of pathology.

[16]  M. Boermeester,et al.  Systemic and local high mobility group box 1 concentrations during severe infection , 2007, Critical care medicine.

[17]  H. Kubo,et al.  The role of the receptor for advanced glycation end-products in lung fibrosis. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[18]  S. Opal,et al.  Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection , 2007, Critical care.

[19]  T. van der Poll,et al.  Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome , 2007, Critical care medicine.

[20]  L. Audoly,et al.  Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.

[21]  E. Chavakis,et al.  A novel pathway of HMGB1‐mediated inflammatory cell recruitment that requires Mac‐1‐integrin , 2007, The EMBO journal.

[22]  D. Foell,et al.  S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules , 2007, Journal of leukocyte biology.

[23]  M. Bianchi.  DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.

[24]  D. Stern,et al.  RAGE in inflammation: a new therapeutic target? , 2006, Current opinion in investigational drugs.

[25]  R. Hotchkiss,et al.  Apoptosis and caspases regulate death and inflammation in sepsis , 2006, Nature Reviews Immunology.

[26]  M. Zorzetto,et al.  The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? , 2006, Modern Pathology.

[27]  H. Harris,et al.  Alarmin(g) news about danger , 2006, EMBO reports.

[28]  E. Abraham,et al.  Anti-High-Mobility Group Box Chromosomal Protein 1 Antibodies Improve Survival of Rats with Sepsis , 2006, World Journal of Surgery.

[29]  K. Tracey,et al.  Role of HMGB1 in apoptosis-mediated sepsis lethality , 2006, The Journal of Experimental Medicine.

[30]  K. Tracey,et al.  Role of HMGB1 in apoptosis-mediated sepsis lethality. , 2006, The Journal of experimental medicine.

[31]  M. Matthay,et al.  Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. , 2006, American journal of respiratory and critical care medicine.

[32]  E. Rieber,et al.  Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells , 2006, Cell and Tissue Research.

[33]  K. Tsuneyama,et al.  Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs , 2005, Modern Pathology.

[34]  A. Schmidt,et al.  Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[35]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[36]  T. Kislinger,et al.  RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-α and NF-κB , 2005, The Journal of experimental medicine.

[37]  Masaki Tanaka,et al.  Contributions of high mobility group box protein in experimental and clinical acute lung injury. , 2004, American journal of respiratory and critical care medicine.

[38]  K. Tracey,et al.  Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis , 2004, Nature Medicine.

[39]  E. Schleicher,et al.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. , 2004, The Journal of clinical investigation.

[40]  E. Abraham,et al.  Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein* , 2004, Journal of Biological Chemistry.

[41]  K. Tracey,et al.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  K. Preissner,et al.  The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins , 2003, The Journal of experimental medicine.

[43]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[44]  A. Schmidt,et al.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.

[45]  A. Waring,et al.  Calcitermin, a novel antimicrobial peptide isolated from human airway secretions , 2001, FEBS letters.

[46]  T. Kislinger,et al.  Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. , 2001, The American journal of pathology.

[47]  R. Hotchkiss,et al.  Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte , 2000, Nature Immunology.

[48]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[49]  M. Müller,et al.  Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. , 1998, Cellular and molecular biology.

[50]  A. Schmidt,et al.  Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts , 1998, Nature Medicine.

[51]  A. Bierhaus,et al.  Pneumococcal Pneumonia Products Impairs Host Defense in The Receptor for Advanced Glycation End , 2009 .

[52]  L. Audoly,et al.  Toll-like receptor 9 – dependent activation by DNA-containing immune complexes is mediated by HMGB 1 and RAGE , 2007 .

[53]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.